Advertisement

Chronic kidney disease (CKD) News

alt
A clinical trial of 4,304 participants with CKD revealed that dapagliflozin reduces the rate of kidney function decline in patients with chronic kidney disease (CKD).






Loading...
english news
NEWS ON ONE CLICK